The Rise of the Data-Miner Whistleblowers

There’s a shift afoot that’s reshaping the False Claims Act (FCA) landscape: the rise of the data-mining whistleblower. This shift has prompted the U.S. Department of Justice (DOJ) to launch an initiative to try to contain and bring some order to it.

For decades, the classic qui tam relator was an insider — an employee who saw something wrong and came forward to report their employer. While that’s still happening, a new breed of relator has emerged: the whistleblower outsider, who never worked a day at the company they’re suing. Instead, they mine publicly available data, such as Medicare billing files, Paycheck Protection Program (PPP) loan records, and corporate filings, looking for statistical outliers that suggest fraud.

A look at the numbers tells you just how fast this trend has grown. Total False Claims Act filings jumped from about 980 in the 2024 fiscal year (FY) to a record roughly 1,300 in FY 2025 — and nearly 800 more were filed in just the first half of FY 2026. Since FY 2024, more than 45 percent of all qui tam complaints have come from these data-driven relators. That is nearly half of everything DOJ is seeing.

Part of what’s fueling this dramatic rise is technology. Artificial intelligence (AI) tools now make it far easier to generate a statistical narrative of fraud on government programs that looks compelling on its face — even when the underlying pattern has a perfectly innocent explanation. And that’s exactly the tension DOJ is trying to manage.

This past April, DOJ rolled out something called the FOCUS initiative — which stands for Fraud Oversight through Careful Use of Statistics. It’s voluntary, not mandatory, but it invites would-be data-miner whistleblowers to sit down with the DOJ Civil Fraud Section before they file, and explain what makes their methodology reliable, rather than speculative. Specifically, the FOCUS initiative asks data-analyst firms to “explain what differentiates their approach, how they validate their findings, and why their methodology provides a reliable basis for identifying high-quality, actionable False Claims Act matters.”

In the last few weeks, DOJ has given that invitation real teeth, with the advent of a formal questionnaire. Prospective relators now are asked to submit a white paper — capped at 10 pages — laying out the fraud theory, the federal program involved, their data sources and assumptions, whether they consulted subject-matter experts, and how they tested their model’s accuracy. Critically, the questionnaire also requires them to address the innocent, non-fraudulent explanations for the pattern they found, tie their signal back to specific statutes or contract terms violated, and disclose their own track record, including prior qui tam filings, their credentials, and any financial ties to the industry they’re scrutinizing. DOJ says it’ll follow up with a meeting only when the analysis shows a signal with a genuinely strong correlation to fraud that the government doesn’t already know about.

In other words, DOJ is telling data miners “bring us the qui tam cases grounded in rigorous analysis, not the slop.”

And the courts have already been signaling something similar. Integra Med Analytics, a data-mining firm that has built its business around bringing qui tam cases using publicly available data (with a mixed track record of success), has run into repeated appellate losses in cases in which statistical modeling stood alone, without ruling out lawful explanations.

But data mining isn’t being shut out entirely — far from it. Just this past May, vascular practice Serrano Kidney & Vascular Access Center and its founder, Dr. Feliciano Serrano, settled for over $6 million after data-analyst whistleblower Lincoln Analytics flagged stent billing at 30 times the national average in a qui tam case in which DOJ hadn’t even intervened. Firms like Verity Investigations and GNGH2 have become genuine repeat players, together driving dozens of resolved qui tam matters and tens of millions in recoveries just in the first seven months of this year in cases alleging PPP loan fraud.

So, here’s the bottom line: data-miner whistleblowing isn’t going away, and DOJ isn’t trying to kill it. But the bar is rising. Sophisticated, validated, well-contextualized analysis and methodologies can absolutely get the government’s attention. Sloppy pattern-spotting, dressed up to look rigorous, increasingly will not.

Facebook
Twitter
LinkedIn

Mary Inman, Esq.

Mary Inman is a partner and co-founder of Whistleblower Partners LLP, a law firm dedicated to representing whistleblowers under the various U.S. whistleblower reward programs. Mary and her colleagues have pioneered a series of successful whistleblower cases against prominent health insurers, hospitals, provider groups, and vendors under the False Claims Act alleging manipulation of the risk scores of Medicare Advantage patients. Mary is a recognized expert and frequent author, commentator, and speaker on frauds in the healthcare industry, particularly those exposed by whistleblowers. Mary is a member of the RACmonitor editorial board and a popular panelist on Monitor Monday.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

One Chart, Five Truths: How CDI Prevents the Same Diagnosis from Becoming Five Different Outcomes

What happens when everyone reviews the same chart, but reaches a different conclusion? In this case-based clinical documentation integrity (CDI) webcast, Penny Jefferson examines how documentation involving clinical support, timing, causation, linkage, and terminology can produce very different outcomes for ICD-10 coding, reimbursement, quality, risk adjustment, medical necessity, denials, and compliance. Using cases involving postoperative respiratory failure, severe malnutrition, and encephalopathy, you’ll learn the practical CLEAR framework to help attendees learn to evaluate whether a diagnosis is codeable, consistent, specific, reportable, and ultimately defensible across the different teams and systems that rely on the medical record.

September 30, 2026

Mastering Spinal Fusion Coding for Inpatient Facilities: ICD-10-PCS Precision, Documentation, and MS-DRG Impact

Spinal fusion cases are among the most complex inpatient procedures to code, where even minor ICD-10-PCS errors can affect MS-DRG assignment, reimbursement, compliance, and audit outcomes. This practical webcast provides a step-by-step framework for interpreting operative reports, assigning accurate ICD-10-PCS codes, recognizing documentation gaps, and confidently coding complex fusion procedures. You’ll leave with practical tools that improve coding accuracy, reduce denials and audit risk, and strengthen documentation-driven reimbursement decisions.

July 29, 2026

AI, Audits, and the Future of the Revenue Cycle

Artificial intelligence is rapidly transforming healthcare revenue cycle operations, from coding and auditing to compliance and denials. Join industry leaders Pam Warren (MaineHealth) and Raemarie Jimenez (AAPC) for a live fireside chat exploring how AI is changing workflows, workforce roles, payer-provider dynamics, and compliance risk—and what organizations should be doing now to prepare.

Webcast Only Available On ICD10monitor Subscription – Subscribe Below

June 17, 2026

Trending News

Featured Webcasts

Radiation Oncology Fundamentals: Coding, Billing & Compliance for Hospital Outpatient & Professional Services

Join Michael Calahan, PA, MBA for this radiation oncology coding and compliance webcast as he explains the fundamentals of coding, billing, reporting, and documentation for hospital outpatient and professional services. Learn how the 2026 radiation therapy coding changes affect current practices, how to distinguish technical and professional services, and how to address bundling, units, frequency, modifiers, and documentation requirements. Michael will also help you identify radiation oncology coding and billing vulnerabilities that could lead to denials, overpayments, repayment demands, or federal audit exposure.

October 20, 2026

CMS Compliance & Audit Readiness Bundle

Get two essential perspectives on CMS compliance for $199.

The Two-Midnight Rule helps you navigate short-stay admissions, patient status, and evolving 2026-2027 requirements, while CMS CRUSH explores the next wave of program integrity, payment oversight, and data-driven scrutiny.

Two RACmonitor webcasts. One practical approach to preparing for increased CMS oversight.

September 20, 2026

Preparing for 2027: Inpatient & Outpatient Policy Changes for Case Management and Utilization Review

The 2027 CMS policy changes will impact case management, utilization review, reimbursement, and patient status decision-making long before they officially take effect. Join nationally recognized physician advisor Dr. Ronald Hirsch as he explains the finalized and proposed inpatient and outpatient rule changes, expanding bundled payment initiatives, payment updates, and evolving payer expectations. Gain practical guidance to help your organization prepare early, strengthen compliance, reduce reimbursement risk, and confidently navigate the transition to 2027.

September 17, 2026

Trending News

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→

Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24